Literature DB >> 28661724

SIRT1 and SIRT6 Signaling Pathways in Cardiovascular Disease Protection.

Nunzia D'Onofrio1, Luigi Servillo1, Maria Luisa Balestrieri1.   

Abstract

SIGNIFICANCE: Oxidative stress represents the common hallmark of pathological conditions associated with cardiovascular disease (CVD), including atherosclerosis, heart failure, hypertension, aging, diabetes, and other vascular system-related diseases. The sirtuin (SIRT) family, comprising seven proteins (SIRT1-SIRT7) sharing a highly conserved nicotinamide adenine dinucleotide (NAD+)-binding catalytic domain, attracted a great attention for the past few years as stress adaptor and epigenetic enzymes involved in the cellular events controlling aging-related disorder, cancer, and CVD. Recent Advances: Among sirtuins, SIRT1 and SIRT6 are the best characterized for their protective roles against inflammation, vascular aging, heart disease, and atherosclerotic plaque development. This latest role has been only recently unveiled for SIRT6. Of interest, in recent years, complex signaling networks controlled by SIRT1 and SIRT6 common to stress resistance, vascular aging, and CVD have emerged. CRITICAL ISSUES: We provide a comprehensive overview of recent developments on the molecular signaling pathways controlled by SIRT1 and SIRT6, two post-translational modifiers proven to be valuable tools to dampen inflammation and oxidative stress at the cardiovascular level. FUTURE DIRECTIONS: A deeper understanding of the epigenetic mechanisms through which SIRT1 and SIRT6 act in the signalings responsible for onset and development CVD is a prime scientific endeavor of the upcoming years. Multiple "omic" technologies will have widespread implications in understanding such mechanisms, speeding up the achievement of selective and efficient pharmacological modulation of sirtuins for future applications in the prevention and treatment of CVD. Antioxid. Redox Signal. 28, 711-732.

Entities:  

Keywords:  SIRT1; SIRT6; cardiovascular disease; endothelial dysfunction; oxidative stress; vascular aging

Mesh:

Substances:

Year:  2017        PMID: 28661724      PMCID: PMC5824538          DOI: 10.1089/ars.2017.7178

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  220 in total

1.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

2.  Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6.

Authors:  Rongya Tao; Xiwen Xiong; Ronald A DePinho; Chu-Xia Deng; X Charlie Dong
Journal:  J Lipid Res       Date:  2013-07-23       Impact factor: 5.922

Review 3.  Caveolin1/protein arginine methyltransferase1/sirtuin1 axis as a potential target against endothelial dysfunction.

Authors:  Soniya Charles; Vijay Raj; Jesu Arokiaraj; Kanchana Mala
Journal:  Pharmacol Res       Date:  2017-01-23       Impact factor: 7.658

Review 4.  Cross-talk between SIRT1 and p66Shc in vascular diseases.

Authors:  Hou-Zao Chen; Yan-Zhen Wan; De-Pei Liu
Journal:  Trends Cardiovasc Med       Date:  2013-03-15       Impact factor: 6.677

5.  Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6.

Authors:  Eriko Michishita; Ronald A McCord; Lisa D Boxer; Matthew F Barber; Tao Hong; Or Gozani; Katrin F Chua
Journal:  Cell Cycle       Date:  2009-08-26       Impact factor: 4.534

6.  Endothelial sirtuin 1 deficiency perpetrates nephrosclerosis through downregulation of matrix metalloproteinase-14: relevance to fibrosis of vascular senescence.

Authors:  Radovan Vasko; Sandhya Xavier; Jun Chen; Chi Hua Sarah Lin; Brian Ratliff; May Rabadi; Julien Maizel; Rina Tanokuchi; Frank Zhang; Jian Cao; Michael S Goligorsky
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

7.  The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression.

Authors:  Melroy X Miranda; Lambertus J van Tits; Christine Lohmann; Tasneem Arsiwala; Stephan Winnik; Anne Tailleux; Sokrates Stein; Ana P Gomes; Vipin Suri; James L Ellis; Thomas A Lutz; Michael O Hottiger; David A Sinclair; Johan Auwerx; Kristina Schoonjans; Bart Staels; Thomas F Lüscher; Christian M Matter
Journal:  Eur Heart J       Date:  2014-03-06       Impact factor: 29.983

8.  A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers.

Authors:  Vincenzo Libri; Andrew P Brown; Giulio Gambarota; Jonathan Haddad; Gregory S Shields; Helen Dawes; David J Pinato; Ethan Hoffman; Peter J Elliot; George P Vlasuk; Eric Jacobson; Martin R Wilkins; Paul M Matthews
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 9.  Crossing the LINE Toward Genomic Instability: LINE-1 Retrotransposition in Cancer.

Authors:  Jacqueline R Kemp; Michelle S Longworth
Journal:  Front Chem       Date:  2015-12-16       Impact factor: 5.221

10.  Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death.

Authors:  D Guan; J H Lim; L Peng; Y Liu; M Lam; E Seto; H-Y Kao
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

View more
  94 in total

1.  Plasma exosomes in OSA patients promote endothelial senescence: effect of long-term adherent continuous positive airway pressure.

Authors:  Abdelnaby Khalyfa; Jose M Marin; Zhuanhong Qiao; David Sanz Rubio; Leila Kheirandish-Gozal; David Gozal
Journal:  Sleep       Date:  2020-02-13       Impact factor: 5.849

2.  Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics.

Authors:  Suowen Xu; Danielle Kamato; Peter J Little; Shinichi Nakagawa; Jaroslav Pelisek; Zheng Gen Jin
Journal:  Pharmacol Ther       Date:  2018-11-13       Impact factor: 12.310

3.  Overexpression of HOTAIR attenuates Pi-induced vascular calcification by inhibiting Wnt/β-catenin through regulating miR-126/Klotho/SIRT1 axis.

Authors:  Yan Chen; Chong Huang; Shu-Ying Zhu; Hong-Chang Zou; Cheng-Yun Xu; Yan-Xia Chen
Journal:  Mol Cell Biochem       Date:  2021-05-20       Impact factor: 3.396

Review 4.  Sirtuins and the circadian clock interplay in cardioprotection: focus on sirtuin 1.

Authors:  Sanjeev Kumar Soni; Priyoneel Basu; Muniyandi Singaravel; Ramaswamy Sharma; Seithikurippu R Pandi-Perumal; Daniel P Cardinali; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2021-01-03       Impact factor: 9.261

Review 5.  Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways.

Authors:  Jie Wang A; Jingjing Zhang; Mengjie Xiao; Shudong Wang; Jie Wang B; Yuanfang Guo; Yufeng Tang; Junlian Gu
Journal:  Cell Mol Life Sci       Date:  2021-01-13       Impact factor: 9.261

6.  Alpha-mangostin decreased cellular senescence in human umbilical vein endothelial cells.

Authors:  Hourieh Tousian; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  Daru       Date:  2019-12-03       Impact factor: 3.117

Review 7.  Emerging potential benefits of modulating NAD+ metabolism in cardiovascular disease.

Authors:  Daniel S Matasic; Charles Brenner; Barry London
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-22       Impact factor: 4.733

Review 8.  Regulation of Nrf2 signaling pathway in heart failure: Role of extracellular vesicles and non-coding RNAs.

Authors:  Changhai Tian; Lie Gao; Irving H Zucker
Journal:  Free Radic Biol Med       Date:  2021-03-17       Impact factor: 7.376

Review 9.  Cardiac Energy Metabolism in Heart Failure.

Authors:  Gary D Lopaschuk; Qutuba G Karwi; Rong Tian; Adam R Wende; E Dale Abel
Journal:  Circ Res       Date:  2021-05-13       Impact factor: 17.367

Review 10.  Emerging roles of SIRT6 in human diseases and its modulators.

Authors:  Gang Liu; Haiying Chen; Hua Liu; Wenbo Zhang; Jia Zhou
Journal:  Med Res Rev       Date:  2020-12-16       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.